Get the latest Science News and Discoveries

Stanford’s Innovative Blood Test Offers New Hope for Hodgkin Lymphoma Patients

Circulating tumor DNA predicts recurrence and splits disease into two subgroups in Stanford Medicine-led study of Hodgkin lymphoma. New drug targets or changes in treatments may reduce toxicity. A Stanford Medicine-led, international study of hundreds of samples from patients with Hodgkin lymphom

None

Get the Android app